Bronte Capital
The sometimes eccentric views of John Hempton
Friday, June 13, 2014
Valeant Pharmaceuticals: Part IIIA: Corrections and amplifications on the Medicis restructuring charges
›
This post contains corrections and amplifications to and of the previous post - which is why it labelled Part IIIA. This is a series - it wi...
23 comments:
Thursday, June 12, 2014
Valeant Pharmaceuticals Part III: Assessing the one-off charges from the Medicis merger
›
In Part II of this series I explained how to look at Valeant Pharmaceutics GAAP and non-GAAP accounts. In particular I showed how the GAAP ...
34 comments:
‹
›
Home
View web version